|
|
|
CUSIP No. 868168105
|
|
Page
5
of 9 Pages
|
This Amendment No. 1 to the joint statement on Schedule 13D with respect to the common
stock, par value $0.01 per share (the Common Stock), of Superior Industries International, Inc., a Delaware corporation (the Issuer), filed by the Reporting Persons (as defined below) on September 3, 2021
(such joint statement, as amended herein, the Schedule 13D), amends the Schedule 13D as follows:
1.
|
Paragraphs (a), (b) and (c) of Item 5 of the Schedule 13D shall hereby be amended and restated in full as
follows:
|
Item 5. Interest in Securities of the Issuer
(a, b) The percentages of beneficial ownership reported in this Item 5, and on each Reporting Persons cover page to this
Schedule 13D, are based on a total of 26,107,462 shares of Common Stock issued and outstanding as of July 30, 2021, as reported in the most recent quarterly report of the Issuer on Form 10-Q for the
fiscal quarter ended June 30, 2021. All of the share numbers reported below, and on each Reporting Persons cover page to this Schedule 13D, are as of September 3, 2021, unless otherwise indicated. The cover page to this Schedule 13D
for each Reporting Person is incorporated by reference in its entirety into this Item 5(a, b).
The Fund directly holds,
and thus has sole voting and dispositive power over, 1,796,202 shares of Common Stock. The GP, as sole general partner of the Fund, also has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on
behalf of the Fund, and Mr. Lynch has shared authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the GP. Accordingly, each of the Reporting Persons beneficially owns 1,796,202 shares
of Common Stock, or approximately 6.9% of the outstanding shares of Common Stock, and the Reporting Persons beneficially own, in the aggregate, 1,796,202 shares of Common Stock, or approximately 6.9% of the outstanding shares of Common Stock.
(c) Except as otherwise described in this Schedule 13D, no Reporting Person, other than the Fund as set forth in the table
below, effected any transaction in shares of the Common Stock during the period (the Reporting Period) from July 5, 2021 (the date 60 days prior to the filing of this Schedule 13D) to September 3, 2021:
|
|
|
|
|
|
|
|
|
Date of Purchase
|
|
Shares
Purchased (#)
|
|
|
Purchase Price
per Share ($)
|
|
7/6/2021
|
|
|
23,151
|
|
|
$
|
8.0369
|
|
7/7/2021
|
|
|
17,759
|
|
|
$
|
7.9739
|
|
7/7/2021
|
|
|
27,344
|
|
|
$
|
7.9806
|
|
7/8/2021
|
|
|
601
|
|
|
$
|
7.8483
|
|
7/8/2021
|
|
|
9,000
|
|
|
$
|
7.8994
|
|
7/14/2021
|
|
|
6,000
|
|
|
$
|
8.0628
|
|
7/14/2021
|
|
|
30,854
|
|
|
$
|
8.0690
|
|
7/15/2021
|
|
|
29,336
|
|
|
$
|
7.9862
|
|
7/15/2021
|
|
|
17,000
|
|
|
$
|
8.0008
|
|
7/16/2021
|
|
|
21,157
|
|
|
$
|
7.8927
|
|
7/16/2021
|
|
|
59,729
|
|
|
$
|
7.9191
|
|
7/19/2021
|
|
|
18,424
|
|
|
$
|
7.6786
|
|